TBIO Financial Facts
Other, net: -1KOther Income (Expense): -274K
See Full Income Statement
Other long-term liabilities: 212K
Other assets: 58K
See Full Balance Sheet
Transgenomic (TBIO) Earnings
|
Expand Research on TBIO
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +11.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.0% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/6/24 | Q224 | N/A | -$3.78 | N/A | N/A | $8.4M | N/A | N/A | N/A | ||
| 5/8/24 | Q124 | N/A | -$0.23 | N/A | N/A | $7M | N/A | N/A | N/A | ||
| 3/25/24 | Q423 | N/A | -$0.27 | N/A | N/A | $9.5M | N/A | N/A | N/A | ||
| 3/19/24 | Q423 | N/A | -$0.27 | N/A | N/A | $9.5M | N/A | N/A | N/A | ||
| 11/13/23 | Q323 | -$0.37 | -$0.30 | -$0.07 | $5.6M | $7.4M | N/A |  | | Details | |
| 11/7/23 | Q323 | N/A | -$0.30 | N/A | N/A | $7.4M | N/A | N/A | N/A | ||
8/10/23  |
Q223 | N/A | -$0.32 | N/A | N/A | $8.6M | N/A | N/A | N/A | ||
| 5/11/23 | Q123 | -$0.37 | -$0.38 | +$0.01 | $6.31M | $6.8M | N/A | | | Details |
